Vivo Capital Fund VIII, L.P.

Titular del 10% en TREX WIND-DOWN, INC. · registrado desde May 1, 2017
Titular del 10% en VYNE Therapeutics Inc. · registrado desde Jan 29, 2018
Titular del 10% en Crinetics Pharmaceuticals, Inc. · registrado desde Jul 20, 2018
Titular del 10% en Kadmon Holdings, LLC · registrado desde Jan 8, 2019
Titular del 10% en Aligos Therapeutics, Inc. · registrado desde Oct 20, 2020
Titular del 10% en BOLT TECHNOLOGY CORP · registrado desde Feb 9, 2021
Titular del 10% en Terns Pharmaceuticals, Inc. · registrado desde Feb 9, 2021
Titular del 10% en IMPERIAL INDUSTRIES INC · registrado desde Apr 29, 2021

Actividad de operaciones de iniciados de Vivo Capital Fund VIII, L.P.

Operaciones registradas: 40; desde May 1, 2017

Compras en el mercado: 10; $20.7M

Ventas en el mercado: 7; $4.5M

Empresas operadas: 4; última notificación Feb 9, 2021

Cifras calculadas a partir de notificaciones regulatorias oficiales — .

Empresas donde Vivo Capital Fund VIII, L.P. ha operado

Terns Pharmaceuticals, Inc.9 ops. · $8.1M · Feb 9, 2021
Crinetics Pharmaceuticals, Inc.19 ops. · $11.1M · Apr 7, 2020
VYNE Therapeutics Inc.10 ops. · $5M · Jan 29, 2018
TREX WIND-DOWN, INC.2 ops. · $1M · May 1, 2017

Historial de resultados de Vivo Capital Fund VIII, L.P.

Historial de resultados estadístico

Free

Compras en el mercado: 11

Última compra: Feb 9, 2021

Las tasas de acierto y las rentabilidades medianas están disponibles con una cuenta gratuita (5 iniciados/mes).

Historial de operaciones de Vivo Capital Fund VIII, L.P.

Co-iniciados de Vivo Capital Fund VIII, L.P.

Vivo Capital VIII, LLCAligos Therapeutics, Inc. +6

Esta página republica notificaciones regulatorias públicas.

Empresa	Notificado	Tipo	Cant.	Precio	Valor · USD	Fuente
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-98,484	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Otro	266,948	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Compra	357,353	17.00 USD	$6.1M	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-713,203	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-364,138	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Compra	103,372	17.00 USD	$1.8M	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-50,282	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Otro	1,933,185	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Compra	14,275	17.00 USD	$242.7K	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-742	14.20 USD	$10.5K	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-5,373	14.20 USD	$76.3K	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-263,600	13.80 USD	$3.6M	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-36,400	13.80 USD	$502.3K	SEC
Crinetics Pharmaceuticals, Inc.	Feb 6, 2020	Venta	-2,584	22.80 USD	$58.9K	SEC
Crinetics Pharmaceuticals, Inc.	Feb 6, 2020	Venta	-357	22.80 USD	$8.1K	SEC
Crinetics Pharmaceuticals, Inc.	Feb 6, 2020	Venta	-10,519	22.80 USD	$239.8K	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	OtroD (derivado)	-1,358,903	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Otro	2,560,613	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	OtroD (derivado)	-1,163,311	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Otro	57,035	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Compra	51,686	17.00 USD	$878.7K	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Compra	153,180	20.73 USD	$3.2M	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Compra	7,137	17.00 USD	$121.3K	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	OtroD (derivado)	-187,648	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Otro	413,040	—	—	SEC

Empresa	Notificado	Tipo	Cant.	Precio	Valor · USD	Fuente
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-98,484	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Otro	266,948	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Compra	357,353	17.00 USD	$6.1M	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-713,203	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-364,138	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Compra	103,372	17.00 USD	$1.8M	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	OtroD (derivado)	-50,282	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Otro	1,933,185	—	—	SEC
Terns Pharmaceuticals, Inc.	Feb 9, 2021	Compra	14,275	17.00 USD	$242.7K	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-742	14.20 USD	$10.5K	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-5,373	14.20 USD	$76.3K	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-263,600	13.80 USD	$3.6M	SEC
Crinetics Pharmaceuticals, Inc.	Apr 7, 2020	Venta	-36,400	13.80 USD	$502.3K	SEC
Crinetics Pharmaceuticals, Inc.	Feb 6, 2020	Venta	-2,584	22.80 USD	$58.9K	SEC
Crinetics Pharmaceuticals, Inc.	Feb 6, 2020	Venta	-357	22.80 USD	$8.1K	SEC
Crinetics Pharmaceuticals, Inc.	Feb 6, 2020	Venta	-10,519	22.80 USD	$239.8K	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	OtroD (derivado)	-1,358,903	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Otro	2,560,613	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	OtroD (derivado)	-1,163,311	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Otro	57,035	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Compra	51,686	17.00 USD	$878.7K	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Compra	153,180	20.73 USD	$3.2M	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Compra	7,137	17.00 USD	$121.3K	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	OtroD (derivado)	-187,648	—	—	SEC
Crinetics Pharmaceuticals, Inc.	Jul 20, 2018	Otro	413,040	—	—	SEC